☆ 4.8 Article

Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications

GASTROENTEROLOGY (2021)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study

Nabeel Khan et al.

Summary: A nationwide retrospective cohort study in the US Veterans' Affairs healthcare system found that patients with inflammatory bowel disease (IBD) did not have a significantly increased risk of developing SARS-CoV-2 infection compared to patients without IBD.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Gastroenterology & Hepatology

Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System

Nabeel Khan et al.

Summary: In a nationwide cohort of patients with IBD, vedolizumab and corticosteroids were associated with an increased risk of SARS-CoV-2 infection. Except for corticosteroids, no medications including mesalazine were associated with an increased risk of severe COVID-19.

GUT (2021)

Add to Collection

Article Gastroenterology & Hepatology

Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

Nicholas A. Kennedy et al.

Summary: The study found that patients with inflammatory bowel disease treated with infliximab had attenuated serological responses to SARS-CoV-2 infection. Additionally, the serological response to SARS-CoV-2 infection in the infliximab-treated group was further blunted by concomitant use of immunomodulators.

GUT (2021)

Add to Collection

Review Multidisciplinary Sciences

Pathway paradigms revealed from the genetics of inflammatory bowel disease

Daniel B. Graham et al.

NATURE (2020)

Add to Collection

Article Gastroenterology & Hepatology

2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases

Carlos Taxonera et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Add to Collection

Letter Gastroenterology & Hepatology

Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts

Mariangela Allocca et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection

Editorial Material Gastroenterology & Hepatology

SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California

John Gubatan et al.

GASTROENTEROLOGY (2020)

Add to Collection

Review Multidisciplinary Sciences

SARS-CoV-2 vaccines in development

Florian Krammer

NATURE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study

Nabeel Khan et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

Julien Kirchgesner et al.

GASTROENTEROLOGY (2018)

Add to Collection

Article Critical Care Medicine

Immortal time bias in observational studies of time-to-event outcomes

Mark Jones et al.

JOURNAL OF CRITICAL CARE (2016)

Add to Collection

Review Gastroenterology & Hepatology

Inflammatory Bowel Disease and the Elderly: A Review

Sasha Taleban et al.

JOURNAL OF CROHNS & COLITIS (2015)

Add to Collection

Article Mathematical & Computational Biology

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies

Peter C. Austin et al.

STATISTICS IN MEDICINE (2015)

Add to Collection

Review Urology & Nephrology

Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies

Jiannong Liu et al.

KIDNEY INTERNATIONAL (2012)

Add to Collection

Article Gastroenterology & Hepatology

Immunosuppression Impairs Response to Pneumococcal Polysaccharide Vaccination in Patients With Inflammatory Bowel Disease

Gil Y. Melmed et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Add to Collection

Article Mathematical & Computational Biology

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

Peter C. Austin

STATISTICS IN MEDICINE (2009)

Add to Collection

Review Gastroenterology & Hepatology

Infections and IBD

Peter M. Irving et al.

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.